Bergenstal RM, Wysham C, Macconell L, Malloy J, Walsh B, Yan P, et al
SLU-PP-332 Research Compound ERR Agonist | 500 MCG Tablet $ 79.00 SLU-PP-332: A cutting-edge ERR agonist research compound studied for mitochondrial fat oxidation pathways
That work isolated a protein from human gastric juice, named it Body Protection Compound (BPC), and defined partial sequences including the 15-amino-acid sequence later designated BPC-157

Step 1: Medical assessment Before switching, your prescriber will evaluate: Your current Mounjaro dose and how long youve been on it Your weight loss progress so far Any side effects youve experienced Your overall health status and any other medications Your reasons for wanting to switch Step 2: Timing the transition Take your final Mounjaro injection as scheduled Wait for the interval recommended by your prescriber (commonly 7 days, though this may vary) Start Wegovy at the dose recommended by your prescriber Continue injecting on the same day each week Step 3: Dose escalation If youre starting at a lower Wegovy dose than your maintenance target, youll follow this escalation schedule: 0.25 mg for 4 weeks 0.5 mg for 4 weeks 1 mg for 4 weeks 1.7 mg for 4 weeks 2.4 mg maintenance dose Your prescriber may adjust this schedule based on your starting dose and your response
People with kidney disease, seizure disorders, thyroid issues, or pregnant women should consult a doctor first.